Print

Glenmark Pharmaceuticals, Sanofi (France) (SAN.PA) in $345 Million Drug-Licensing Pact  
5/3/2010 9:03:11 AM

WSJ -- India's Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France's Sanofi-Aventis S.A.
//-->